Research Analysis: Use Neuromodulation for CRPS Sooner not Later

A research analysis published in Neuromodulation: Technology at the Neural Interface concluded that clinicians should consider spinal cord stimulation (SCS) earlier than as a last resort for the treatment of complex regional pain syndrome (CRPS).  SCS has been FDA-approved for the treatment of neuropathic trunk and limb pain since 1989 and involves a slender electrical lead implanted under the skin of the back to deliver a mild electrical current to the spinal cord. The analysis found that to facilitate functional rehabilitation in CRPS, SCS should be considered as soon as more conservative therapies have failed – after perhaps three months. Read a news report here.

Posted on August 4, 2013

Related Content

• Medication Assisted Therapy--Getting Primary Care On-board
• Receptor May Aid in Advancing New Osteoporosis Treatment Therapies
• Acupuncture for Women With Vulvar Pain--A New Treatment Option?
• IVIg vs Placebo: The Search for CRPS Treatment Medications Continues
• A Chronic Pain Survey: Homeless Older Adults Living on the Streets
• Understanding IBD and Treating Crohn's Disease--A New Early Warning?
• Topical Analgesics as a Treatment Alternative to Opioids, Prescription NSAIDs
• Neuromodulation as Chronic Pain Therapy
• Spinal Manipulative Therapy - Effective, and for Whom?
• Technology: Smart Shoe Insoles to Reduce Pain in Knee Osteoarthritis?